The first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease is completed by a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Bird flu virus had been discovered in the bodies of eight dead birds found in the state of Bavaria, the southern German city of Nuremberg.
Aiming to protect the almost 40 million men, women and children living with HIV from potential stigma and discrimination, the main United Nations agency dealing with AIDS released new guidelines to ensure that patient confidentiality is not compromised in the process of collecting and storing information on the virus.
Treatment with the oral antiviral Tamiflu (oseltamivir) and prophylaxis for people exposed to infected patients could be one of the most cost-effective strategies for reducing illness and death during an influenza pandemic.
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
amfAR, The Foundation for AIDS Research, will grant almost $1.2 million for 10 new research projects aimed at increasing understanding of the social and biological factors that influence the treatment of HIV/AIDS, Dr. Rowena Johnston, amfAR?s vice president of research.
Human resistance to a retrovirus that infected chimpanzees and other nonhuman primates 4 million years ago ironically may be at least partially responsible for the susceptibility of humans to HIV infection today.
In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease.
Neurologix, Inc. (OTC Bulletin Board: NRGX) today announced the publication in the June 23 issue of the journal The Lancet of positive results from the first ever gene therapy trial for Parkinson?s disease and the first report of direct gene transfer into a patient?s own brain cells for any adult neurodegenerative disease.
The UK Government has announced that girls aged 12 will be offered vaccination against the human papilomavirus (HPV) ? the virus which causes the majority of cervical cancers.